Atlas Trials

Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast Cancer

Clinical trial NCT06222879 · RECRUITING

Trial details

NCT number
NCT06222879
Sponsor
Shandong Suncadia Medicine Co., Ltd.
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2024-02-20
Primary completion
2026-10-31
Enrollment
350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.